{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:04:06Z","timestamp":1768824246989,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Females spend a third to half of their life in menopause, and the number of US females in menopause is growing. A high percentage of postmenopausal females experience bothersome, sometimes debilitating genitourinary symptoms, which can affect quality of life. The genitourinary syndrome of menopause (GSM) describes the condition previously referred to as vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy. Of concern, many patients with symptoms of GSM have never been asked about nor have they initiated conversations about these concerns with a healthcare provider. This article addresses the need to improve screening, identification, and patient-centered management in primary care of females with GSM.<\/jats:p>","DOI":"10.1097\/01.jaa.0000947048.98796.4d","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T18:09:47Z","timestamp":1691690987000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A practical guide to managing genitourinary syndrome of menopause in primary care"],"prefix":"10.1097","volume":"36","author":[{"given":"Elizabeth","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"10","key":"R1-20250605","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"issue":"5","key":"R2-20250605","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/GME.0000000000001728","article-title":"The genitourinary syndrome of menopause","volume":"28","author":"Phillips","year":"2021","journal-title":"Menopause"},{"issue":"6","key":"R3-20250605","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/GME.0000000000001752","article-title":"Genitourinary syndrome of menopause: a systematic review on prevalence and treatment","volume":"28","author":"Mili","year":"2021","journal-title":"Menopause"},{"issue":"7","key":"R5-20250605","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J Sex Med"},{"issue":"9","key":"R6-20250605","first-page":"976","article-title":"The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society","volume":"27","author":"Faubion","year":"2020","journal-title":"Menopause"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.maturitas.2015.09.001","article-title":"Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study","volume":"83","author":"Palma","year":"2016","journal-title":"Maturitas"},{"issue":"6","key":"R8-20250605","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fcimb.2019.00133","article-title":"The current evidence on the association between the urinary microbiome and urinary incontinence in women","volume":"9","author":"Govender","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"R11-20250605","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0b013e318282600b","article-title":"The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women","volume":"20","author":"Erekson","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"R12-20250605","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: How important is vaginal lubricant and moisturizer composition","volume":"19","author":"Edwards","year":"2016","journal-title":"Climacteric"},{"issue":"1","key":"R13-20250605","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697137.2020.1820478","article-title":"Vaginal lubricants and moisturizers: a review into use, efficacy, and safety","volume":"24","author":"Potter","year":"2021","journal-title":"Climacteric"},{"issue":"1","key":"R14-20250605","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1071\/SH11095","article-title":"Condom use errors and problems: a global view","volume":"9","author":"Sanders","year":"2012","journal-title":"Sex Health"},{"issue":"1","key":"R15-20250605","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jsxm.2020.10.016","article-title":"Hyaluronic acid in postmenopause vaginal atrophy: a systematic review","volume":"18","author":"dos Santos","year":"2021","journal-title":"J Sex Med"},{"issue":"1","key":"R16-20250605","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6118\/jmm.21028","article-title":"Vaginal vitamin E for treatment of genitourinary syndrome of menopause: a systematic review of randomized controlled trials","volume":"28","author":"Porterfield","year":"2022","journal-title":"J Menopausal Med"},{"issue":"8","key":"R17-20250605","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"R18-20250605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"issue":"6","key":"R19-20250605","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/GME.0000000000001284","article-title":"Vaginal estrogen use and chronic disease risk in the Nurses' Health Study","volume":"26","author":"Bhupathiraju","year":"2018","journal-title":"Menopause"},{"issue":"10","key":"R20-20250605","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40266-019-00700-w","article-title":"Practical treatment considerations in the management of genitourinary syndrome of menopause","volume":"36","author":"Kagan","year":"2019","journal-title":"Drugs Aging"},{"issue":"6","key":"R21-20250605","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women's Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"issue":"7","key":"R22-20250605","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14656566.2019.1574752","article-title":"Pharmacotherapy for the treatment of vaginal atrophy","volume":"20","author":"Donders","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"R23-20250605","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09513590.2020.1757058","article-title":"Ospemifene efficacy and safety data in women with vulvovaginal atrophy","volume":"36","author":"Pup","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2018.11.016","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part I: evaluation of efficacy","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"issue":"6","key":"R25-20250605","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/GME.0000000000000808","article-title":"Science of intracrinology in postmenopausal women","volume":"24","author":"Labrie","year":"2017","journal-title":"Menopause"},{"issue":"1","key":"R26-20250605","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/GME.0000000000000958","article-title":"Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopause","volume":"25","author":"Kagan","year":"2018","journal-title":"Menopause"},{"issue":"8","key":"R27-20250605","first-page":"S265","article-title":"Pelvic floor muscle training as a treatment approach for genitourinary syndrome of menopause","volume":"37","author":"Mercier","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"R28-20250605","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/AOG.0000000000004860","article-title":"Commercially available home pelvic training devices for the treatment of pelvic floor disorders","volume":"140","author":"Pennycuff","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"11","key":"R30-20250605","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/GME.0000000000001845","article-title":"Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khamis","year":"2021","journal-title":"Menopause"},{"issue":"3","key":"R31-20250605","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jsxm.2021.12.010","article-title":"CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis","volume":"19","author":"Filippini","year":"2022","journal-title":"J Sex Med"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000947048.98796.4d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:04:12Z","timestamp":1749153852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000947048.98796.4d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000947048.98796.4d","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}